Article

Key Endothelial Signals Required for Hematopoietic Recovery

Wilmot Cancer Center and Endocrine Division, University of Rochester School of Medicine, 601 Elmwood Avenue, Box 693, Rochester, NY 14642, USA.
Cell stem cell (Impact Factor: 22.27). 04/2009; 4(3):187-8. DOI: 10.1016/j.stem.2009.02.005
Source: PubMed

ABSTRACT

In this issue of Cell Stem Cell, Hooper et al. (2009) use a combination of immunohistochemistry and flow cytometry to characterize the bone marrow vasculature both before and after injury. The authors demonstrate that recovery of normal hematopoiesis after myelosuppressive insult is dependent upon endothelial VEGFR2.

  • Source
    • "Many groups have helped to characterise the bone marrow stem cell niche(s) (Adams et al. 2007, Frisch et al. 2008, Porter and Calvi 2008, Raymond et al. 2009) and, in terms of regulation, have shown that it occurs through cells within the bone marrow microenvironment, an environment that includes, for example, the osteoblasts (Calvi et al. 2003), osteoclasts (Kollet et al. 2006), and endothelial cells (Porter and Calvi 2009), and is likely maintained through cell-cell and cell-extracellular matrix interactions. With respect to radiation injury specifically, some investigators have shown that the bone marrow stem cell niche is relatively hypoxic (Parmar et al. 2007) and since the stem cells appear to exist in a quiescent or very slowly cycling state (Harrison and Astle 1982, Schaniel and Moore 2009) they are therefore, relatively radio-resistant. "
    [Show abstract] [Hide abstract]
    ABSTRACT: PURPOSE: There is increasing concern that, since the Cold War era, there has been little progress regarding the availability of medical countermeasures in the event of either a radiological or nuclear incident. Fortunately, since much is known about the acute consequences that are likely to be experienced by an exposed population, the probability of survival from the immediate hematological crises after total body irradiation (TBI) has improved in recent years. Therefore focus has begun to shift towards later down-stream effects, seen in such organs as the gastrointestinal tract (GI), skin, and lung. However, the mechanisms underlying therapy-related normal tissue late effects, resulting from localised irradiation, have remained somewhat elusive and even less is known about the development of the delayed syndrome seen in the context of whole body exposures, when it is likely that systemic perturbations may alter tissue microenvironments and homeostasis. CONCLUSIONS: The sequence of organ failures observed after near-lethal TBI doses are similar in many ways to that of multiple organ dysfunction syndrome (MODS), leading to multiple organ failure (MOF). In this review, we compare the mechanistic pathways that underlie both MODS and delayed normal tissue effects since these may impact on strategies to identify radiation countermeasures.
    Full-text · Article · Mar 2011 · International Journal of Radiation Biology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hematopoietic stem cells (HSCs) are the most well-characterized tissue-specific stem cell. Over 50 years of basic research and clinical application has provided insight into the molecular and cellular mechanisms of HSC biology. HSC undergo self-renewal by symmetric or asymmetric division, or differentiation to common myeloid progenitors and progressively more differentiated myeloid and lymphoid progeny. The chemokine SDF-1/ CXCL12 produced by marrow reticular cells plays a central role in regulating HSC migration and homing. HSC reside within a three-dimensional multicellular signaling unit or “niche” within the bone marrow. Within the niche HSC can be sustained in a dormant G0 state. Accumulating genetic and functional data indicate molecular cross-talk between HSCs and osteoblasts, endothelial cells, and perivascular reticular cells that compose the endosteal and vascular niches. This involves large number of molecules (cytokines, chemokines, integrins, morphogens, and their receptors). The cytokines c-Kit ligand and thrombopoietin in particular are critical for HSC maintenance and self-renewal. The morphogens (Notch ligands, Wnt, Hedgehog, TGFβ, and BMP) also have variable and overlapping roles in supporting HSC self-renewal. Many of these secreted signaling molecules bind to the extracellular matrix and do not diffuse far or are presented by niche cells in transmembrane form (e.g., Jagged-Notch, Kit Ligand-c-Kit, Angiopoietin1-Tie2). Increased understanding of the molecular basis of HSC regulation will ultimately lead to protocols for maintenance and expansion of HSCs in vitro for clinical use in cell and gene therapies. KeywordsStem cell–Cytokine–Chemokine–Morphogen–Self-renewal–Asymmetric cell division–Integrins–Niche–Homeobox genes
    No preview · Chapter · Dec 2008
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pancytopenia is a major cause of morbidity in acute myeloid leukemia (AML), yet its cause is unclear. Normal osteoblastic cells have been shown to support hematopoiesis. To define the effects of leukemia on osteoblastic cells, we used an immunocompetent murine model of AML. Leukemic mice had inhibition of osteoblastic cells, with decreased serum levels of the bone formation marker osteocalcin. Osteoprogenitor cells and endosteal-lining osteopontin(+) cells were reduced, and osteocalcin mRNA in CD45(-) marrow cells was diminished. This resulted in severe loss of mineralized bone. Osteoclasts were only transiently increased without significant increases in bone resorption, and their inhibition only partially rescued leukemia-induced bone loss. In vitro data suggested that a leukemia-derived secreted factor inhibited osteoblastic cells. Because the chemokine CCL-3 was recently reported to inhibit osteoblastic function in myeloma, we tested its expression in our model and in AML patients. Consistent with its potential novel role in leukemic-dependent bone loss, CCL-3 mRNA was significantly increased in malignant marrow cells from leukemic mice and from samples from AML patients. Based on these results, we propose that therapeutic mitigation of leukemia-induced uncoupling of osteoblastic and osteoclastic cells may represent a novel approach to promote normal hematopoiesis in patients with myeloid neoplasms.
    Full-text · Article · Sep 2011 · Blood
Show more